Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA PFIZER ASTRAZENECA PHARMA/
PFIZER
 
P/E (TTM) x 95.5 38.2 249.9% View Chart
P/BV x 22.7 6.0 379.4% View Chart
Dividend Yield % 0.3 1.7 18.0%  

Financials

 ASTRAZENECA PHARMA   PFIZER
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
PFIZER
Mar-23
ASTRAZENECA PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3,6204,662 77.6%   
Low Rs2,4383,407 71.6%   
Sales per share (Unadj.) Rs401.2530.0 75.7%  
Earnings per share (Unadj.) Rs39.7136.4 29.1%  
Cash flow per share (Unadj.) Rs46.2159.4 29.0%  
Dividends per share (Unadj.) Rs16.0070.00 22.9%  
Avg Dividend yield %0.51.7 30.4%  
Book value per share (Unadj.) Rs234.4701.0 33.4%  
Shares outstanding (eoy) m25.0045.75 54.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.57.6 99.2%   
Avg P/E ratio x76.329.6 257.8%  
P/CF ratio (eoy) x65.525.3 259.0%  
Price / Book Value ratio x12.95.8 224.5%  
Dividend payout %40.351.3 78.5%   
Avg Mkt Cap Rs m75,718184,576 41.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5913,317 78.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03024,248 41.4%  
Other income Rs m2611,011 25.8%   
Total revenues Rs m10,29125,258 40.7%   
Gross profit Rs m1,2498,420 14.8%  
Depreciation Rs m1631,055 15.4%   
Interest Rs m6135 4.7%   
Profit before tax Rs m1,3418,240 16.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3482,001 17.4%   
Profit after tax Rs m9936,239 15.9%  
Gross profit margin %12.534.7 35.9%  
Effective tax rate %26.024.3 106.9%   
Net profit margin %9.925.7 38.5%  
BALANCE SHEET DATA
Current assets Rs m9,35924,933 37.5%   
Current liabilities Rs m4,8446,574 73.7%   
Net working cap to sales %45.075.7 59.5%  
Current ratio x1.93.8 50.9%  
Inventory Days Days4993 52.9%  
Debtors Days Days392 1,713.2%  
Net fixed assets Rs m2,06113,780 15.0%   
Share capital Rs m50458 10.9%   
"Free" reserves Rs m5,81131,616 18.4%   
Net worth Rs m5,86132,073 18.3%   
Long term debt Rs m00-   
Total assets Rs m11,42139,031 29.3%  
Interest coverage x213.962.1 344.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 141.4%   
Return on assets %8.716.3 53.6%  
Return on equity %16.919.5 87.1%  
Return on capital %23.026.1 88.0%  
Exports to sales %02.8 0.0%   
Imports to sales %37.40 107,841.3%   
Exports (fob) Rs mNA688 0.0%   
Imports (cif) Rs m3,7478 44,607.1%   
Fx inflow Rs m612688 89.0%   
Fx outflow Rs m3,7478 44,607.1%   
Net fx Rs m-3,135679 -461.4%   
CASH FLOW
From Operations Rs m5833,557 16.4%  
From Investments Rs m181-361 -50.2%  
From Financial Activity Rs m-245-3,458 7.1%  
Net Cashflow Rs m519-262 -198.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.3%  
Indian inst/Mut Fund % 5.4 18.2 29.8%  
FIIs % 2.7 3.0 87.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 36.1 69.3%  
Shareholders   29,032 112,456 25.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Pfizer Share Price Performance

Period ASTRAZENECA PHARMA Pfizer S&P BSE HEALTHCARE
1-Day 0.01% -4.80% 1.18%
1-Month -3.61% -8.24% -0.75%
1-Year 59.20% 21.78% 61.82%
3-Year CAGR 20.50% -2.07% 18.16%
5-Year CAGR 22.18% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.